CannMed

CannMed Join us for the CannMed 26 Innovation & Collaboration Summit where innovation and collaboration reach new heights!

Oral & poster presentations, panels, workshops, unique networking events, and more. June 15-18, 2026 at the Hyatt Regency Lake Tahoe Resort. Allow us to introduce you to the CannMed 23 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world. Since 2016, CannMed has regularly featured some of the greatest minds in med

icinal plant medicine, cultivation, and safety testing. It is the most sought-after forum in which to announce the latest research and technologies while networking with current and prospective customers. In this supercharged environment, CannMed 23 gathers stakeholders from across the industry, along with leaders from financial institutions who come together to forge enduring partnerships. To facilitate maximum exposure to the latest scientific discoveries, the meeting format kicks off with pre-conference workshops on the capital markets, a medical practicum, and deep dives into cultivation and laboratory technology. The summit will feature a curated list of speakers and abstract-selected talks in an immersive format that reflects state of the art across the broad landscape of medicinal crops. Partnership is the most powerful way to showcase your company and products to a targeted audience of top global leaders and key decision-makers. We look forward to working with you to advance the industry.

Relive the highlights of the CannMed 26 Innovation & Collaboration Summit at Lake Tahoe. Explore our photo gallery to se...
07/10/2026

Relive the highlights of the CannMed 26 Innovation & Collaboration Summit at Lake Tahoe. Explore our photo gallery to see snapshots from this year’s event!

View Gallery: https://hubs.li/Q04p9Gx50

Brought to you by: Medicinal Genomics & Advanced Nutrients

04/22/2026

NEW CannMed Coffee Talk Podcast, we discuss AI and Machine Learning in Medical Cannabis.

Dr. Hemant Kumar Bid serves as Program Director for the Morehouse School of Medicine. He has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.

During our conversation, we discuss:

- How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data.
- Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success
- Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.

Watch now: https://hubs.li/Q04d4_C60

Thanks to Tikun Olam USA for sponsoring!

04/22/2026

NEW CANNMED COFFEE TALK PODCAST

Dr. Hemant Kumar Bid serves as Program Director for the Morehouse School of Medicine, and has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.

During our conversation we discuss:

How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data.

Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success

Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.

Watch and listen on YouTube and all podcast apps!

Thanks to for sponsoring!

Address

100 Cummings Center
Beverly, MA
01915

Alerts

Be the first to know and let us send you an email when CannMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CannMed:

Shortcuts

Share